Global IVD Infectious Diseases Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 309808
  • calendar_today Published On: Jun, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The IVD Infectious Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global IVD Infectious Diseases market size is estimated to be worth US$ 17100 million in 2021 and is forecast to a readjusted size of USD 21950 million by 2028 with a CAGR of 3.6% during review period. Clinical Laboratories accounting for % of the IVD Infectious Diseases global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Immunochemistry segment is altered to a % CAGR between 2022 and 2028.

Global key companies of IVD Infectious Diseases include BD, BioMerieux, Abbott, Quidel, and Gen-Probe, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

IVD Infectious Diseases market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Immunochemistry

Molecular Diagnostics

Market segment by Application, can be divided into

Clinical Laboratories

Diagnostic Centers

Market segment by players, this report covers

BD

BioMerieux

Abbott

Quidel

Gen-Probe

Abbott

Danaher

Sysmex

Orasure

Hologic

Cepheid

Qiagen

Roche Diagnostics

Siemens Healthcare

Bio-Rad Laboratories

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe IVD Infectious Diseases product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of IVD Infectious Diseases, with revenue, gross margin and global market share of IVD Infectious Diseases from 2019 to 2022.

Chapter 3, the IVD Infectious Diseases competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and IVD Infectious Diseases market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe IVD Infectious Diseases research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of IVD Infectious Diseases

1.2 Classification of IVD Infectious Diseases by Type

1.2.1 Overview: Global IVD Infectious Diseases Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global IVD Infectious Diseases Revenue Market Share by Type in 2021

1.2.3 Immunochemistry

1.2.4 Molecular Diagnostics

1.3 Global IVD Infectious Diseases Market by Application

1.3.1 Overview: Global IVD Infectious Diseases Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Clinical Laboratories

1.3.3 Diagnostic Centers

1.4 Global IVD Infectious Diseases Market Size & Forecast

1.5 Global IVD Infectious Diseases Market Size and Forecast by Region

1.5.1 Global IVD Infectious Diseases Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global IVD Infectious Diseases Market Size by Region, (2017-2022)

1.5.3 North America IVD Infectious Diseases Market Size and Prospect (2017-2028)

1.5.4 Europe IVD Infectious Diseases Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific IVD Infectious Diseases Market Size and Prospect (2017-2028)

1.5.6 South America IVD Infectious Diseases Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa IVD Infectious Diseases Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 IVD Infectious Diseases Market Drivers

1.6.2 IVD Infectious Diseases Market Restraints

1.6.3 IVD Infectious Diseases Trends Analysis

2 Company Profiles

2.1 BD

2.1.1 BD Details

2.1.2 BD Major Business

2.1.3 BD IVD Infectious Diseases Product and Solutions

2.1.4 BD IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 BD Recent Developments and Future Plans

2.2 BioMerieux

2.2.1 BioMerieux Details

2.2.2 BioMerieux Major Business

2.2.3 BioMerieux IVD Infectious Diseases Product and Solutions

2.2.4 BioMerieux IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 BioMerieux Recent Developments and Future Plans

2.3 Abbott

2.3.1 Abbott Details

2.3.2 Abbott Major Business

2.3.3 Abbott IVD Infectious Diseases Product and Solutions

2.3.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Abbott Recent Developments and Future Plans

2.4 Quidel

2.4.1 Quidel Details

2.4.2 Quidel Major Business

2.4.3 Quidel IVD Infectious Diseases Product and Solutions

2.4.4 Quidel IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Quidel Recent Developments and Future Plans

2.5 Gen-Probe

2.5.1 Gen-Probe Details

2.5.2 Gen-Probe Major Business

2.5.3 Gen-Probe IVD Infectious Diseases Product and Solutions

2.5.4 Gen-Probe IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Gen-Probe Recent Developments and Future Plans

2.6 Abbott

2.6.1 Abbott Details

2.6.2 Abbott Major Business

2.6.3 Abbott IVD Infectious Diseases Product and Solutions

2.6.4 Abbott IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Abbott Recent Developments and Future Plans

2.7 Danaher

2.7.1 Danaher Details

2.7.2 Danaher Major Business

2.7.3 Danaher IVD Infectious Diseases Product and Solutions

2.7.4 Danaher IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Danaher Recent Developments and Future Plans

2.8 Sysmex

2.8.1 Sysmex Details

2.8.2 Sysmex Major Business

2.8.3 Sysmex IVD Infectious Diseases Product and Solutions

2.8.4 Sysmex IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Sysmex Recent Developments and Future Plans

2.9 Orasure

2.9.1 Orasure Details

2.9.2 Orasure Major Business

2.9.3 Orasure IVD Infectious Diseases Product and Solutions

2.9.4 Orasure IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Orasure Recent Developments and Future Plans

2.10 Hologic

2.10.1 Hologic Details

2.10.2 Hologic Major Business

2.10.3 Hologic IVD Infectious Diseases Product and Solutions

2.10.4 Hologic IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10.5 Hologic Recent Developments and Future Plans

2.11 Cepheid

2.11.1 Cepheid Details

2.11.2 Cepheid Major Business

2.11.3 Cepheid IVD Infectious Diseases Product and Solutions

2.11.4 Cepheid IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11.5 Cepheid Recent Developments and Future Plans

2.12 Qiagen

2.12.1 Qiagen Details

2.12.2 Qiagen Major Business

2.12.3 Qiagen IVD Infectious Diseases Product and Solutions

2.12.4 Qiagen IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12.5 Qiagen Recent Developments and Future Plans

2.13 Roche Diagnostics

2.13.1 Roche Diagnostics Details

2.13.2 Roche Diagnostics Major Business

2.13.3 Roche Diagnostics IVD Infectious Diseases Product and Solutions

2.13.4 Roche Diagnostics IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13.5 Roche Diagnostics Recent Developments and Future Plans

2.14 Siemens Healthcare

2.14.1 Siemens Healthcare Details

2.14.2 Siemens Healthcare Major Business

2.14.3 Siemens Healthcare IVD Infectious Diseases Product and Solutions

2.14.4 Siemens Healthcare IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14.5 Siemens Healthcare Recent Developments and Future Plans

2.15 Bio-Rad Laboratories

2.15.1 Bio-Rad Laboratories Details

2.15.2 Bio-Rad Laboratories Major Business

2.15.3 Bio-Rad Laboratories IVD Infectious Diseases Product and Solutions

2.15.4 Bio-Rad Laboratories IVD Infectious Diseases Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15.5 Bio-Rad Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global IVD Infectious Diseases Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 IVD Infectious Diseases Players Market Share in 2021

3.2.2 Top 10 IVD Infectious Diseases Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 IVD Infectious Diseases Players Head Office, Products and Services Provided

3.4 IVD Infectious Diseases Mergers & Acquisitions

3.5 IVD Infectious Diseases New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global IVD Infectious Diseases Revenue and Market Share by Type (2017-2022)

4.2 Global IVD Infectious Diseases Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global IVD Infectious Diseases Revenue Market Share by Application (2017-2022)

5.2 Global IVD Infectious Diseases Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America IVD Infectious Diseases Revenue by Type (2017-2028)

6.2 North America IVD Infectious Diseases Revenue by Application (2017-2028)

6.3 North America IVD Infectious Diseases Market Size by Country

6.3.1 North America IVD Infectious Diseases Revenue by Country (2017-2028)

6.3.2 United States IVD Infectious Diseases Market Size and Forecast (2017-2028)

6.3.3 Canada IVD Infectious Diseases Market Size and Forecast (2017-2028)

6.3.4 Mexico IVD Infectious Diseases Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe IVD Infectious Diseases Revenue by Type (2017-2028)

7.2 Europe IVD Infectious Diseases Revenue by Application (2017-2028)

7.3 Europe IVD Infectious Diseases Market Size by Country

7.3.1 Europe IVD Infectious Diseases Revenue by Country (2017-2028)

7.3.2 Germany IVD Infectious Diseases Market Size and Forecast (2017-2028)

7.3.3 France IVD Infectious Diseases Market Size and Forecast (2017-2028)

7.3.4 United Kingdom IVD Infectious Diseases Market Size and Forecast (2017-2028)

7.3.5 Russia IVD Infectious Diseases Market Size and Forecast (2017-2028)

7.3.6 Italy IVD Infectious Diseases Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific IVD Infectious Diseases Revenue by Type (2017-2028)

8.2 Asia-Pacific IVD Infectious Diseases Revenue by Application (2017-2028)

8.3 Asia-Pacific IVD Infectious Diseases Market Size by Region

8.3.1 Asia-Pacific IVD Infectious Diseases Revenue by Region (2017-2028)

8.3.2 China IVD Infectious Diseases Market Size and Forecast (2017-2028)

8.3.3 Japan IVD Infectious Diseases Market Size and Forecast (2017-2028)

8.3.4 South Korea IVD Infectious Diseases Market Size and Forecast (2017-2028)

8.3.5 India IVD Infectious Diseases Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia IVD Infectious Diseases Market Size and Forecast (2017-2028)

8.3.7 Australia IVD Infectious Diseases Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America IVD Infectious Diseases Revenue by Type (2017-2028)

9.2 South America IVD Infectious Diseases Revenue by Application (2017-2028)

9.3 South America IVD Infectious Diseases Market Size by Country

9.3.1 South America IVD Infectious Diseases Revenue by Country (2017-2028)

9.3.2 Brazil IVD Infectious Diseases Market Size and Forecast (2017-2028)

9.3.3 Argentina IVD Infectious Diseases Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa IVD Infectious Diseases Revenue by Type (2017-2028)

10.2 Middle East & Africa IVD Infectious Diseases Revenue by Application (2017-2028)

10.3 Middle East & Africa IVD Infectious Diseases Market Size by Country

10.3.1 Middle East & Africa IVD Infectious Diseases Revenue by Country (2017-2028)

10.3.2 Turkey IVD Infectious Diseases Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia IVD Infectious Diseases Market Size and Forecast (2017-2028)

10.3.4 UAE IVD Infectious Diseases Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global IVD Infectious Diseases Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global IVD Infectious Diseases Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market IVD Infectious Diseases Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global IVD Infectious Diseases Revenue (USD Million) by Region (2017-2022)

Table 5. Global IVD Infectious Diseases Revenue Market Share by Region (2023-2028)

Table 6. BD Corporate Information, Head Office, and Major Competitors

Table 7. BD Major Business

Table 8. BD IVD Infectious Diseases Product and Solutions

Table 9. BD IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. BioMerieux Corporate Information, Head Office, and Major Competitors

Table 11. BioMerieux Major Business

Table 12. BioMerieux IVD Infectious Diseases Product and Solutions

Table 13. BioMerieux IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Abbott Corporate Information, Head Office, and Major Competitors

Table 15. Abbott Major Business

Table 16. Abbott IVD Infectious Diseases Product and Solutions

Table 17. Abbott IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Quidel Corporate Information, Head Office, and Major Competitors

Table 19. Quidel Major Business

Table 20. Quidel IVD Infectious Diseases Product and Solutions

Table 21. Quidel IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Gen-Probe Corporate Information, Head Office, and Major Competitors

Table 23. Gen-Probe Major Business

Table 24. Gen-Probe IVD Infectious Diseases Product and Solutions

Table 25. Gen-Probe IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Abbott Corporate Information, Head Office, and Major Competitors

Table 27. Abbott Major Business

Table 28. Abbott IVD Infectious Diseases Product and Solutions

Table 29. Abbott IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Danaher Corporate Information, Head Office, and Major Competitors

Table 31. Danaher Major Business

Table 32. Danaher IVD Infectious Diseases Product and Solutions

Table 33. Danaher IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Sysmex Corporate Information, Head Office, and Major Competitors

Table 35. Sysmex Major Business

Table 36. Sysmex IVD Infectious Diseases Product and Solutions

Table 37. Sysmex IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Orasure Corporate Information, Head Office, and Major Competitors

Table 39. Orasure Major Business

Table 40. Orasure IVD Infectious Diseases Product and Solutions

Table 41. Orasure IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Hologic Corporate Information, Head Office, and Major Competitors

Table 43. Hologic Major Business

Table 44. Hologic IVD Infectious Diseases Product and Solutions

Table 45. Hologic IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 46. Cepheid Corporate Information, Head Office, and Major Competitors

Table 47. Cepheid Major Business

Table 48. Cepheid IVD Infectious Diseases Product and Solutions

Table 49. Cepheid IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 50. Qiagen Corporate Information, Head Office, and Major Competitors

Table 51. Qiagen Major Business

Table 52. Qiagen IVD Infectious Diseases Product and Solutions

Table 53. Qiagen IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 54. Roche Diagnostics Corporate Information, Head Office, and Major Competitors

Table 55. Roche Diagnostics Major Business

Table 56. Roche Diagnostics IVD Infectious Diseases Product and Solutions

Table 57. Roche Diagnostics IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 58. Siemens Healthcare Corporate Information, Head Office, and Major Competitors

Table 59. Siemens Healthcare Major Business

Table 60. Siemens Healthcare IVD Infectious Diseases Product and Solutions

Table 61. Siemens Healthcare IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 62. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 63. Bio-Rad Laboratories Major Business

Table 64. Bio-Rad Laboratories IVD Infectious Diseases Product and Solutions

Table 65. Bio-Rad Laboratories IVD Infectious Diseases Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 66. Global IVD Infectious Diseases Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 67. Global IVD Infectious Diseases Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 68. Breakdown of IVD Infectious Diseases by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. IVD Infectious Diseases Players Head Office, Products and Services Provided

Table 70. IVD Infectious Diseases Mergers & Acquisitions in the Past Five Years

Table 71. IVD Infectious Diseases New Entrants and Expansion Plans

Table 72. Global IVD Infectious Diseases Revenue (USD Million) by Type (2017-2022)

Table 73. Global IVD Infectious Diseases Revenue Share by Type (2017-2022)

Table 74. Global IVD Infectious Diseases Revenue Forecast by Type (2023-2028)

Table 75. Global IVD Infectious Diseases Revenue by Application (2017-2022)

Table 76. Global IVD Infectious Diseases Revenue Forecast by Application (2023-2028)

Table 77. North America IVD Infectious Diseases Revenue by Type (2017-2022) & (USD Million)

Table 78. North America IVD Infectious Diseases Revenue by Type (2023-2028) & (USD Million)

Table 79. North America IVD Infectious Diseases Revenue by Application (2017-2022) & (USD Million)

Table 80. North America IVD Infectious Diseases Revenue by Application (2023-2028) & (USD Million)

Table 81. North America IVD Infectious Diseases Revenue by Country (2017-2022) & (USD Million)

Table 82. North America IVD Infectious Diseases Revenue by Country (2023-2028) & (USD Million)

Table 83. Europe IVD Infectious Diseases Revenue by Type (2017-2022) & (USD Million)

Table 84. Europe IVD Infectious Diseases Revenue by Type (2023-2028) & (USD Million)

Table 85. Europe IVD Infectious Diseases Revenue by Application (2017-2022) & (USD Million)

Table 86. Europe IVD Infectious Diseases Revenue by Application (2023-2028) & (USD Million)

Table 87. Europe IVD Infectious Diseases Revenue by Country (2017-2022) & (USD Million)

Table 88. Europe IVD Infectious Diseases Revenue by Country (2023-2028) & (USD Million)

Table 89. Asia-Pacific IVD Infectious Diseases Revenue by Type (2017-2022) & (USD Million)

Table 90. Asia-Pacific IVD Infectious Diseases Revenue by Type (2023-2028) & (USD Million)

Table 91. Asia-Pacific IVD Infectious Diseases Revenue by Application (2017-2022) & (USD Million)

Table 92. Asia-Pacific IVD Infectious Diseases Revenue by Application (2023-2028) & (USD Million)

Table 93. Asia-Pacific IVD Infectious Diseases Revenue by Region (2017-2022) & (USD Million)

Table 94. Asia-Pacific IVD Infectious Diseases Revenue by Region (2023-2028) & (USD Million)

Table 95. South America IVD Infectious Diseases Revenue by Type (2017-2022) & (USD Million)

Table 96. South America IVD Infectious Diseases Revenue by Type (2023-2028) & (USD Million)

Table 97. South America IVD Infectious Diseases Revenue by Application (2017-2022) & (USD Million)

Table 98. South America IVD Infectious Diseases Revenue by Application (2023-2028) & (USD Million)

Table 99. South America IVD Infectious Diseases Revenue by Country (2017-2022) & (USD Million)

Table 100. South America IVD Infectious Diseases Revenue by Country (2023-2028) & (USD Million)

Table 101. Middle East & Africa IVD Infectious Diseases Revenue by Type (2017-2022) & (USD Million)

Table 102. Middle East & Africa IVD Infectious Diseases Revenue by Type (2023-2028) & (USD Million)

Table 103. Middle East & Africa IVD Infectious Diseases Revenue by Application (2017-2022) & (USD Million)

Table 104. Middle East & Africa IVD Infectious Diseases Revenue by Application (2023-2028) & (USD Million)

Table 105. Middle East & Africa IVD Infectious Diseases Revenue by Country (2017-2022) & (USD Million)

Table 106. Middle East & Africa IVD Infectious Diseases Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. IVD Infectious Diseases Picture

Figure 2. Global IVD Infectious Diseases Revenue Market Share by Type in 2021

Figure 3. Immunochemistry

Figure 4. Molecular Diagnostics

Figure 5. IVD Infectious Diseases Revenue Market Share by Application in 2021

Figure 6. Clinical Laboratories Picture

Figure 7. Diagnostic Centers Picture

Figure 8. Global IVD Infectious Diseases Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 9. Global IVD Infectious Diseases Revenue and Forecast (2017-2028) & (USD Million)

Figure 10. Global IVD Infectious Diseases Revenue Market Share by Region (2017-2028)

Figure 11. Global IVD Infectious Diseases Revenue Market Share by Region in 2021

Figure 12. North America IVD Infectious Diseases Revenue (USD Million) and Growth Rate (2017-2028)

Figure 13. Europe IVD Infectious Diseases Revenue (USD Million) and Growth Rate (2017-2028)

Figure 14. Asia-Pacific IVD Infectious Diseases Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. South America IVD Infectious Diseases Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Middle East and Africa IVD Infectious Diseases Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. IVD Infectious Diseases Market Drivers

Figure 18. IVD Infectious Diseases Market Restraints

Figure 19. IVD Infectious Diseases Market Trends

Figure 20. BD Recent Developments and Future Plans

Figure 21. BioMerieux Recent Developments and Future Plans

Figure 22. Abbott Recent Developments and Future Plans

Figure 23. Quidel Recent Developments and Future Plans

Figure 24. Gen-Probe Recent Developments and Future Plans

Figure 25. Abbott Recent Developments and Future Plans

Figure 26. Danaher Recent Developments and Future Plans

Figure 27. Sysmex Recent Developments and Future Plans

Figure 28. Orasure Recent Developments and Future Plans

Figure 29. Hologic Recent Developments and Future Plans

Figure 30. Cepheid Recent Developments and Future Plans

Figure 31. Qiagen Recent Developments and Future Plans

Figure 32. Roche Diagnostics Recent Developments and Future Plans

Figure 33. Siemens Healthcare Recent Developments and Future Plans

Figure 34. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 35. Global IVD Infectious Diseases Revenue Share by Players in 2021

Figure 36. IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 37. Global Top 3 Players IVD Infectious Diseases Revenue Market Share in 2021

Figure 38. Global Top 10 Players IVD Infectious Diseases Revenue Market Share in 2021

Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 40. Global IVD Infectious Diseases Revenue Share by Type in 2021

Figure 41. Global IVD Infectious Diseases Market Share Forecast by Type (2023-2028)

Figure 42. Global IVD Infectious Diseases Revenue Share by Application in 2021

Figure 43. Global IVD Infectious Diseases Market Share Forecast by Application (2023-2028)

Figure 44. North America IVD Infectious Diseases Sales Market Share by Type (2017-2028)

Figure 45. North America IVD Infectious Diseases Sales Market Share by Application (2017-2028)

Figure 46. North America IVD Infectious Diseases Revenue Market Share by Country (2017-2028)

Figure 47. United States IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Canada IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Mexico IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Europe IVD Infectious Diseases Sales Market Share by Type (2017-2028)

Figure 51. Europe IVD Infectious Diseases Sales Market Share by Application (2017-2028)

Figure 52. Europe IVD Infectious Diseases Revenue Market Share by Country (2017-2028)

Figure 53. Germany IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. France IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. United Kingdom IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Russia IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Italy IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Asia-Pacific IVD Infectious Diseases Sales Market Share by Type (2017-2028)

Figure 59. Asia-Pacific IVD Infectious Diseases Sales Market Share by Application (2017-2028)

Figure 60. Asia-Pacific IVD Infectious Diseases Revenue Market Share by Region (2017-2028)

Figure 61. China IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Japan IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. South Korea IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. India IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Southeast Asia IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Australia IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South America IVD Infectious Diseases Sales Market Share by Type (2017-2028)

Figure 68. South America IVD Infectious Diseases Sales Market Share by Application (2017-2028)

Figure 69. South America IVD Infectious Diseases Revenue Market Share by Country (2017-2028)

Figure 70. Brazil IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Argentina IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Middle East and Africa IVD Infectious Diseases Sales Market Share by Type (2017-2028)

Figure 73. Middle East and Africa IVD Infectious Diseases Sales Market Share by Application (2017-2028)

Figure 74. Middle East and Africa IVD Infectious Diseases Revenue Market Share by Country (2017-2028)

Figure 75. Turkey IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. Saudi Arabia IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. UAE IVD Infectious Diseases Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Methodology

Figure 79. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz